Compare JAZZ & CIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JAZZ | CIB |
|---|---|---|
| Founded | 2003 | 1945 |
| Country | Ireland | Colombia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6B | 15.6B |
| IPO Year | 2007 | 2025 |
| Metric | JAZZ | CIB |
|---|---|---|
| Price | $254.86 | $84.04 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 6 |
| Target Price | ★ $217.57 | $70.25 |
| AVG Volume (30 Days) | ★ 789.8K | 325.6K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 1.82% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.43 | N/A |
| Revenue | ★ $1,618,693,000.00 | N/A |
| Revenue This Year | $6.22 | $56.74 |
| Revenue Next Year | $7.68 | $8.05 |
| P/E Ratio | $54.96 | ★ $10.87 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $105.00 | $43.20 |
| 52 Week High | $250.49 | $87.68 |
| Indicator | JAZZ | CIB |
|---|---|---|
| Relative Strength Index (RSI) | 65.44 | 62.67 |
| Support Level | $222.49 | $61.61 |
| Resistance Level | N/A | $86.99 |
| Average True Range (ATR) | 7.53 | 2.03 |
| MACD | 0.49 | -0.19 |
| Stochastic Oscillator | 99.98 | 93.69 |
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Grupo Cibest SA is a full service financial group offering a broad range of financial products and services to a diversified individual and corporate clients through subsidiaries. Its network also includes offshore banking subsidiaries in Panama and Puerto Rico, as well as other adjacent businesses. Its products and services include Savings and Investment, Financing, Factoring, Financial and Operating Leases, Capital Markets, Trading, Cash Management, Foreign Currency and Trade Finance, Bancassurance and Insurance, Investment Banking, Trust and Fiduciary Services, Mortgage Lending Business, among others. Its segments include Banking Colombia, Banking El Salvador, Banking Guatemala, International Banking, Leases, All Other and Banking Panama.